Clinical Trial Detail

NCT ID NCT02354586
Title A Study of Niraparib in Patients With Ovarian Cancer Who Have Received at Least Three Previous Chemotherapy Regimens
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Tesaro, Inc.
Indications

peritoneal serous adenocarcinoma

fallopian tube serous adenocarcinoma

ovary serous adenocarcinoma

Therapies

Niraparib

Age Groups: adult

No variant requirements are available.